Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 36% ± 20% | |
lung | 9 studies | 24% ± 7% | |
eye | 6 studies | 27% ± 13% | |
kidney | 5 studies | 19% ± 3% | |
liver | 4 studies | 32% ± 17% | |
intestine | 4 studies | 21% ± 6% | |
pancreas | 3 studies | 39% ± 18% | |
peripheral blood | 3 studies | 26% ± 3% | |
adipose | 3 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2701.19 | 1445 / 1445 | 100% | 23.95 | 183 / 183 |
lung | 100% | 4252.87 | 577 / 578 | 100% | 20.27 | 1152 / 1155 |
breast | 100% | 3582.13 | 459 / 459 | 99% | 22.87 | 1112 / 1118 |
brain | 99% | 3133.09 | 2625 / 2642 | 100% | 17.25 | 705 / 705 |
thymus | 100% | 4012.27 | 653 / 653 | 99% | 18.84 | 598 / 605 |
ovary | 100% | 3769.32 | 180 / 180 | 99% | 14.14 | 425 / 430 |
prostate | 100% | 3076.01 | 245 / 245 | 99% | 16.07 | 496 / 502 |
stomach | 100% | 4545.99 | 359 / 359 | 99% | 22.71 | 282 / 286 |
intestine | 100% | 4366.54 | 966 / 966 | 98% | 22.25 | 519 / 527 |
kidney | 100% | 3169.80 | 89 / 89 | 98% | 17.32 | 882 / 901 |
pancreas | 99% | 2093.65 | 326 / 328 | 98% | 22.03 | 175 / 178 |
bladder | 100% | 2916.62 | 21 / 21 | 98% | 15.71 | 492 / 504 |
adrenal gland | 100% | 3608.65 | 258 / 258 | 96% | 15.48 | 221 / 230 |
uterus | 100% | 3650.14 | 170 / 170 | 96% | 13.77 | 441 / 459 |
skin | 100% | 3259.90 | 1808 / 1809 | 91% | 17.96 | 430 / 472 |
liver | 100% | 3221.42 | 226 / 226 | 90% | 9.77 | 364 / 406 |
adipose | 100% | 3352.37 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 4145.43 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.96 | 1 / 1 |
blood vessel | 100% | 2839.97 | 1333 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 16.44 | 28 / 29 |
muscle | 97% | 1060.97 | 775 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 1457.10 | 826 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 10.96 | 43 / 45 |
peripheral blood | 82% | 2519.85 | 764 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 53% | 5.89 | 42 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006646 | Biological process | phosphatidylethanolamine biosynthetic process |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004305 | Molecular function | ethanolamine kinase activity |
Gene name | ETNK1 |
Protein name | Ethanolamine kinase 1 (EKI 1) (EC 2.7.1.82) ethanolamine kinase (EC 2.7.1.82) Ethanolamine kinase 1 |
Synonyms | hCG_22726 EKI1 |
Description | FUNCTION: Highly specific for ethanolamine phosphorylation. May be a rate-controlling step in phosphatidylethanolamine biosynthesis. . |
Accessions | ENST00000672951.1 [Q9HBU6-2] Q86U68 H0YFP7 ENST00000671733.1 [Q9HBU6-1] A0A5K1VW28 ENST00000673406.1 ENST00000266517.9 ENST00000538218.2 H0YH69 A0A5F9ZI33 ENST00000545979.2 ENST00000335148.8 Q9HBU6 |